[
    [
        {
            "time": "2023-05-22",
            "original_text": "B racco Imag and Shanghai Pharmaceutials join forces in the field of ultrasound",
            "features": {
                "keywords": [
                    "Shanghai Pharmaceutials",
                    "ultrasound",
                    "join forces"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "Healthcare",
                    "Pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "B racco Imag and Shanghai Pharmaceutials join forces in the field of ultrasound",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-05-22",
            "original_text": "5月22日午间行业热点聚焦",
            "features": {
                "keywords": [
                    "行业热点",
                    "聚焦"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "General Industry"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "5月22日午间行业热点聚焦",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-05-22",
            "original_text": "[增持评级] 上海医药(601607)公司更新报告：工业迎积极变化 估值具提升空间",
            "features": {
                "keywords": [
                    "上海医药",
                    "增持评级",
                    "工业",
                    "积极变化",
                    "估值提升"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "Pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[增持评级] 上海医药(601607)公司更新报告：工业迎积极变化 估值具提升空间",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-22",
            "original_text": "5月以来，国内药企持续上演并购大戏",
            "features": {
                "keywords": [
                    "国内药企",
                    "并购",
                    "持续"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "Pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "5月以来，国内药企持续上演并购大戏",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-05-22",
            "original_text": "[买入评级] 上海医药(601607)点评：收购广东天普26.34%股权 工业羽翼渐丰",
            "features": {
                "keywords": [
                    "上海医药",
                    "买入评级",
                    "收购",
                    "广东天普",
                    "股权",
                    "工业"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "Pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级] 上海医药(601607)点评：收购广东天普26.34%股权 工业羽翼渐丰",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-22",
            "original_text": "医疗保健行业动态：高估值下板块波动加大 确定性依然是核心",
            "features": {
                "keywords": [
                    "医疗保健",
                    "高估值",
                    "波动",
                    "确定性"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "Healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医疗保健行业动态：高估值下板块波动加大 确定性依然是核心",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-05-22",
            "original_text": "保健品业务营收持续下滑 健康元卖子增厚利润",
            "features": {
                "keywords": [
                    "保健品",
                    "营收下滑",
                    "健康元",
                    "卖子",
                    "利润"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "Healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "保健品业务营收持续下滑 健康元卖子增厚利润",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-05-22",
            "original_text": "上药9亿元涉足天然尿蛋白药物",
            "features": {
                "keywords": [
                    "上药",
                    "天然尿蛋白",
                    "药物",
                    "9亿元"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "Pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上药9亿元涉足天然尿蛋白药物",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-22",
            "original_text": "拟1.44亿美元绝对控股天普生化 上海医药加码医药工业",
            "features": {
                "keywords": [
                    "上海医药",
                    "天普生化",
                    "控股",
                    "医药工业",
                    "1.44亿美元"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "Pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "拟1.44亿美元绝对控股天普生化 上海医药加码医药工业",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-22",
            "original_text": "医药生物行业: 中长期持续看好板块",
            "features": {
                "keywords": [
                    "医药生物",
                    "中长期",
                    "看好",
                    "板块"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "Biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业: 中长期持续看好板块",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 4,
                "Duration": 8,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]